Aqemia is a next-gen pharmatech company that discovers drug technology for critical diseases with physics and artificial intelligence.In October 2022, Aqemia raises €30 million in a Series A funding round led by Eurazeo and EPIC Bpifrance through its Large Venture fund, with the participation of Elaia its historic investor